Showing results (201-210 of 215) with videos related to
Sort By:
Pageof 22
Blood|November 9, 2002
A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survivalChristine P Hans, Dennis D Weisenburger, Julie M Vose, et al.Explore (New York, N.Y.)|January 6, 2022
Siddha fasting in obese acute decompensated heart failure may improve hospital outcomes through empowerment and natural ketosisAnand Chockalingam, Senthil Kumar, Mauricio Sendra Ferrer, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2010
Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-kappa B upon TLR4 stimulationMourad Zerfaoui, Youssef Errami, Amarjit S Naura, et al.Leukemia & Lymphoma|July 16, 2005
Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphomaYouli Zu, Seth M Steinberg, Elias Campo, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 28, 2005
Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphomaChristine P Hans, Dennis D Weisenburger, Timothy C Greiner, et al.Frontiers in Physiology|April 15, 2021
Mineralocorticoid Receptor in Myeloid Cells Mediates Angiotensin II-Induced Vascular Dysfunction in Female MiceCamila Manrique-Acevedo, Jaume Padilla, Huma Naz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2008
Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphomaKai Fu, Dennis D Weisenburger, William W L Choi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2007
LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximabYasodha Natkunam, Pedro Farinha, Eric D Hsi, et al.Blood|September 25, 2003
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarrayChristine P Hans, Dennis D Weisenburger, Timothy C Greiner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2006
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphomaJaveed Iqbal, Vishala T Neppalli, George Wright, et al.Pageof 22